← Open Payments lookup

KIMBERLY GIBERGA: Open Payments

NPI 1114250651 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$27,408 in 141 payments from 21 companies in 2025. Trend: 2023 $1,955 · 2024 $4,723 · 2025 $27,408

Speaker / faculty: $22,000Food & beverage: $5,304Travel & lodging: $104
CompanyPaymentsAmount
ABBVIE INC.51$23,249
Axsome Therapeutics, Inc.16$715
Boston Scientific Corporation3$403
Teva Pharmaceuticals USA, Inc.8$378
Janssen Pharmaceuticals, Inc8$341
ABIOMED3$286
E.R. Squibb & Sons, L.L.C.4$265
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$231
Alkermes, Inc.4$207
Lundbeck LLC8$182

Products named: VRAYLAR, Auvelity, REXULTI, SPRAVATO, COBENFY, AMS 700, CAPLYTA, LYBALVI.

Industry payments across TX — which companies pay providers there.